US91324P1021
US91324P1021
UnitedHealth Group Incorporated
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 340.46B EUR | 376.15B EUR | 245.61B EUR | 299.03B EUR |
Enterprise Value | 382.32B EUR | 420.89B EUR | 295.52B EUR | 353.05B EUR |
Valuation Multiples | ||||
Trailing P/E | 24.39x | 26.64x | 20.39x | 51.88x |
Forward P/E | 16.78x | -- | -- | -- |
Price to Sales | 0.76x | 0.84x | 0.55x | 0.88x |
Price to Book | 3.49x | 3.82x | 2.51x | 3.18x |
EV/Revenue | 0.85x | 0.94x | 0.66x | 1.04x |
EV/EBITDA | 14.33x | 16.21x | 12.76x | 26.86x |
Price to FCF (P/FCF) | 14.03x | 15.93x | 12.49x | 25.96x |
EV/FCF | 15.75x | 17.82x | 15.03x | 30.65x |
FCF Yield | 7.13% | 6.28% | 8.01% | 3.85% |